$NKTR Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in NEKTAR THERAPEUTICS.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in NEKTAR THERAPEUTICS. Get notifications about new insider transactions in NEKTAR THERAPEUTICS for free.
Page: < prev 1 ... 3 4 5 6 7 8 9 10 11 ... 12 next >
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov 20 2015 | NKTR | NEKTAR THERAPEUTIC ... | WANG SUSAN | Director | Buy | M | 5.14 | 9,500 | 48,830 | 29,500 | 20 K to 29.5 K (+47.50 %) |
| Nov 20 2015 | NKTR | NEKTAR THERAPEUTIC ... | WANG SUSAN | Director | Sell | S | 15.02 | 15,128 | 227,223 | 20,000 | 35.1 K to 20 K (-43.07 %) |
| Nov 20 2015 | NKTR | NEKTAR THERAPEUTIC ... | WANG SUSAN | Director | Buy | M | 5.14 | 15,128 | 77,758 | 35,128 | 20 K to 35.1 K (+75.64 %) |
| Nov 20 2015 | NKTR | NEKTAR THERAPEUTIC ... | WANG SUSAN | Director | Sell | S | 15.00 | 5,372 | 80,580 | 20,000 | 25.4 K to 20 K (-21.17 %) |
| Nov 20 2015 | NKTR | NEKTAR THERAPEUTIC ... | WANG SUSAN | Director | Buy | M | 5.14 | 5,372 | 27,612 | 25,372 | 20 K to 25.4 K (+26.86 %) |
| Nov 20 2015 | NKTR | NEKTAR THERAPEUTIC ... | WANG SUSAN | Director | Sell | S | 15.00 | 15,000 | 225,000 | 20,000 | 35 K to 20 K (-42.86 %) |
| Nov 20 2015 | NKTR | NEKTAR THERAPEUTIC ... | WANG SUSAN | Director | Buy | M | 8.37 | 15,000 | 125,550 | 35,000 | 20 K to 35 K (+75.00 %) |
| Nov 13 2015 | NKTR | NEKTAR THERAPEUTIC ... | ROBIN HOWARD W | President & CEO | Option Exercise | M | 6.46 | 66,667 | 430,669 | 200,000 | |
| Nov 13 2015 | NKTR | NEKTAR THERAPEUTIC ... | ROBIN HOWARD W | President & CEO | Option Exercise | M | 6.98 | 58,333 | 407,164 | 408,334 | |
| Nov 13 2015 | NKTR | NEKTAR THERAPEUTIC ... | ROBIN HOWARD W | President & CEO | Sell | S | 13.52 | 125,000 | 1,690,000 | 10,000 | 135 K to 10 K (-92.59 %) |
| Nov 13 2015 | NKTR | NEKTAR THERAPEUTIC ... | ROBIN HOWARD W | President & CEO | Buy | M | 6.46 | 66,667 | 430,669 | 135,000 | 68.3 K to 135 K (+97.56 %) |
| Nov 13 2015 | NKTR | NEKTAR THERAPEUTIC ... | ROBIN HOWARD W | President & CEO | Buy | M | 6.98 | 58,333 | 407,164 | 68,333 | 10 K to 68.3 K (+583.33 %) |
| Nov 13 2015 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP & General Couns ... | Option Exercise | M | 6.46 | 11,667 | 75,369 | 35,000 | |
| Nov 13 2015 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP & General Couns ... | Option Exercise | M | 6.98 | 33,333 | 232,664 | 33,334 | |
| Nov 13 2015 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP & General Couns ... | Sell | S | 13.52 | 45,000 | 608,400 | 4,751 | 49.8 K to 4.8 K (-90.45 %) |
| Nov 13 2015 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP & General Couns ... | Buy | M | 6.46 | 11,667 | 75,369 | 49,751 | 38.1 K to 49.8 K (+30.63 %) |
| Nov 13 2015 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP & General Couns ... | Buy | M | 6.98 | 33,333 | 232,664 | 38,084 | 4.8 K to 38.1 K (+701.60 %) |
| Nov 13 2015 | NKTR | NEKTAR THERAPEUTIC ... | Thomsen Jillian B. | SVP & Chief Account ... | Option Exercise | M | 6.65 | 15,000 | 99,750 | 60,000 | |
| Nov 13 2015 | NKTR | NEKTAR THERAPEUTIC ... | Thomsen Jillian B. | SVP & Chief Account ... | Sell | S | 13.52 | 15,000 | 202,800 | 3,499 | 18.5 K to 3.5 K (-81.09 %) |
| Nov 13 2015 | NKTR | NEKTAR THERAPEUTIC ... | Thomsen Jillian B. | SVP & Chief Account ... | Buy | M | 6.65 | 15,000 | 99,750 | 18,499 | 3.5 K to 18.5 K (+428.69 %) |
| Oct 30 2015 | NKTR | NEKTAR THERAPEUTIC ... | Lingnau Lutz | Director | Option Exercise | M | 6.65 | 12,500 | 83,125 | 0 | |
| Oct 30 2015 | NKTR | NEKTAR THERAPEUTIC ... | Lingnau Lutz | Director | Sell | S | 12.00 | 12,500 | 150,000 | 16,450 | 29 K to 16.5 K (-43.18 %) |
| Oct 30 2015 | NKTR | NEKTAR THERAPEUTIC ... | Lingnau Lutz | Director | Buy | M | 6.65 | 12,500 | 83,125 | 28,950 | 16.5 K to 29 K (+75.99 %) |
| Oct 19 2015 | NKTR | NEKTAR THERAPEUTIC ... | GREER R SCOTT | Director | Option Exercise | M | 11.34 | 10,000 | 113,400 | 0 | |
| Oct 19 2015 | NKTR | NEKTAR THERAPEUTIC ... | GREER R SCOTT | Director | Option Exercise | M | 11.34 | 22,500 | 255,150 | 0 | |
| Oct 19 2015 | NKTR | NEKTAR THERAPEUTIC ... | GREER R SCOTT | Director | Buy | M | 11.34 | 10,000 | 113,400 | 83,333 | 73.3 K to 83.3 K (+13.64 %) |
| Oct 19 2015 | NKTR | NEKTAR THERAPEUTIC ... | GREER R SCOTT | Director | Buy | M | 11.34 | 22,500 | 255,150 | 73,333 | 50.8 K to 73.3 K (+44.26 %) |
| Oct 08 2015 | NKTR | NEKTAR THERAPEUTIC ... | ROBIN HOWARD W | President & CEO | Option Exercise | M | 6.46 | 66,667 | 430,669 | 266,667 | |
| Oct 08 2015 | NKTR | NEKTAR THERAPEUTIC ... | ROBIN HOWARD W | President & CEO | Option Exercise | M | 6.98 | 58,333 | 407,164 | 466,667 | |
| Oct 08 2015 | NKTR | NEKTAR THERAPEUTIC ... | ROBIN HOWARD W | President & CEO | Sell | S | 10.99 | 125,000 | 1,373,750 | 10,000 | 135 K to 10 K (-92.59 %) |
| Oct 08 2015 | NKTR | NEKTAR THERAPEUTIC ... | ROBIN HOWARD W | President & CEO | Buy | M | 6.46 | 66,667 | 430,669 | 135,000 | 68.3 K to 135 K (+97.56 %) |
| Oct 08 2015 | NKTR | NEKTAR THERAPEUTIC ... | ROBIN HOWARD W | President & CEO | Buy | M | 6.98 | 58,333 | 407,164 | 68,333 | 10 K to 68.3 K (+583.33 %) |
| Oct 08 2015 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP & General Couns ... | Option Exercise | M | 6.46 | 11,667 | 75,369 | 46,667 | |
| Oct 08 2015 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP & General Couns ... | Option Exercise | M | 6.98 | 33,333 | 232,664 | 66,667 | |
| Oct 08 2015 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP & General Couns ... | Sell | S | 10.99 | 45,000 | 494,550 | 4,751 | 49.8 K to 4.8 K (-90.45 %) |
| Oct 08 2015 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP & General Couns ... | Buy | M | 6.46 | 11,667 | 75,369 | 49,751 | 38.1 K to 49.8 K (+30.63 %) |
| Oct 08 2015 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP & General Couns ... | Buy | M | 6.98 | 33,333 | 232,664 | 38,084 | 4.8 K to 38.1 K (+701.60 %) |
| Oct 08 2015 | NKTR | NEKTAR THERAPEUTIC ... | Thomsen Jillian B. | SVP & Chief Account ... | Option Exercise | M | 6.65 | 15,000 | 99,750 | 75,000 | |
| Oct 08 2015 | NKTR | NEKTAR THERAPEUTIC ... | Thomsen Jillian B. | SVP & Chief Account ... | Sell | S | 10.99 | 15,000 | 164,850 | 3,499 | 18.5 K to 3.5 K (-81.09 %) |
| Oct 08 2015 | NKTR | NEKTAR THERAPEUTIC ... | Thomsen Jillian B. | SVP & Chief Account ... | Buy | M | 6.65 | 15,000 | 99,750 | 18,499 | 3.5 K to 18.5 K (+428.69 %) |
| Sep 25 2015 | NKTR | NEKTAR THERAPEUTIC ... | Thomsen Jillian B. | SVP & Chief Account ... | Option Exercise | M | 6.65 | 10,000 | 66,500 | 90,000 | |
| Sep 25 2015 | NKTR | NEKTAR THERAPEUTIC ... | Thomsen Jillian B. | SVP & Chief Account ... | Sell | S | 13.04 | 10,000 | 130,400 | 3,499 | 13.5 K to 3.5 K (-74.08 %) |
| Sep 25 2015 | NKTR | NEKTAR THERAPEUTIC ... | Thomsen Jillian B. | SVP & Chief Account ... | Buy | M | 6.65 | 10,000 | 66,500 | 13,499 | 3.5 K to 13.5 K (+285.80 %) |
| Sep 25 2015 | NKTR | NEKTAR THERAPEUTIC ... | ROBIN HOWARD W | President & CEO | Option Exercise | M | 6.46 | 66,666 | 430,662 | 333,334 | |
| Sep 25 2015 | NKTR | NEKTAR THERAPEUTIC ... | ROBIN HOWARD W | President & CEO | Option Exercise | M | 6.98 | 58,333 | 407,164 | 525,000 | |
| Sep 25 2015 | NKTR | NEKTAR THERAPEUTIC ... | ROBIN HOWARD W | President & CEO | Sell | S | 13.04 | 124,999 | 1,629,987 | 10,000 | 135 K to 10 K (-92.59 %) |
| Sep 25 2015 | NKTR | NEKTAR THERAPEUTIC ... | ROBIN HOWARD W | President & CEO | Buy | M | 6.46 | 66,666 | 430,662 | 134,999 | 68.3 K to 135 K (+97.56 %) |
| Sep 25 2015 | NKTR | NEKTAR THERAPEUTIC ... | ROBIN HOWARD W | President & CEO | Buy | M | 6.98 | 58,333 | 407,164 | 68,333 | 10 K to 68.3 K (+583.33 %) |
| Sep 25 2015 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP & General Couns ... | Option Exercise | M | 6.46 | 11,666 | 75,362 | 58,334 | |
| Sep 25 2015 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP & General Couns ... | Option Exercise | M | 6.98 | 33,333 | 232,664 | 100,000 | |
| Sep 25 2015 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP & General Couns ... | Sell | S | 13.04 | 44,999 | 586,787 | 4,751 | 49.8 K to 4.8 K (-90.45 %) |
| Sep 25 2015 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP & General Couns ... | Buy | M | 6.46 | 11,666 | 75,362 | 49,750 | 38.1 K to 49.8 K (+30.63 %) |
| Sep 25 2015 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP & General Couns ... | Buy | M | 6.98 | 33,333 | 232,664 | 38,084 | 4.8 K to 38.1 K (+701.60 %) |
| Sep 17 2015 | NKTR | NEKTAR THERAPEUTIC ... | WINGER DENNIS L | Director | Option Exercise | A | 0.00 | 15,000 | 0 | 15,000 | |
| Sep 17 2015 | NKTR | NEKTAR THERAPEUTIC ... | WINGER DENNIS L | Director | Option Exercise | A | 12.80 | 12,500 | 160,000 | 12,500 | |
| Sep 17 2015 | NKTR | NEKTAR THERAPEUTIC ... | WHITFIELD ROY A | Director | Option Exercise | A | 0.00 | 15,000 | 0 | 15,000 | |
| Sep 17 2015 | NKTR | NEKTAR THERAPEUTIC ... | WHITFIELD ROY A | Director | Option Exercise | A | 12.80 | 12,500 | 160,000 | 12,500 | |
| Sep 17 2015 | NKTR | NEKTAR THERAPEUTIC ... | WANG SUSAN | Director | Option Exercise | A | 0.00 | 15,000 | 0 | 15,000 | |
| Sep 17 2015 | NKTR | NEKTAR THERAPEUTIC ... | WANG SUSAN | Director | Option Exercise | A | 12.80 | 12,500 | 160,000 | 12,500 | |
| Sep 17 2015 | NKTR | NEKTAR THERAPEUTIC ... | Lingnau Lutz | Director | Option Exercise | A | 0.00 | 15,000 | 0 | 15,000 | |
| Sep 17 2015 | NKTR | NEKTAR THERAPEUTIC ... | Lingnau Lutz | Director | Option Exercise | A | 12.80 | 12,500 | 160,000 | 12,500 | |
| Sep 17 2015 | NKTR | NEKTAR THERAPEUTIC ... | KUEBLER CHRISTOPHER A | Director | Option Exercise | A | 0.00 | 15,000 | 0 | 15,000 | |
| Sep 17 2015 | NKTR | NEKTAR THERAPEUTIC ... | KUEBLER CHRISTOPHER A | Director | Option Exercise | A | 12.80 | 12,500 | 160,000 | 12,500 | |
| Sep 17 2015 | NKTR | NEKTAR THERAPEUTIC ... | Krivulka Joseph J | Director | Option Exercise | A | 0.00 | 15,000 | 0 | 15,000 | |
| Sep 17 2015 | NKTR | NEKTAR THERAPEUTIC ... | Krivulka Joseph J | Director | Option Exercise | A | 12.80 | 12,500 | 160,000 | 12,500 | |
| Sep 17 2015 | NKTR | NEKTAR THERAPEUTIC ... | GREER R SCOTT | Director | Option Exercise | A | 0.00 | 15,000 | 0 | 15,000 | |
| Sep 17 2015 | NKTR | NEKTAR THERAPEUTIC ... | GREER R SCOTT | Director | Option Exercise | A | 12.80 | 12,500 | 160,000 | 12,500 | |
| Sep 17 2015 | NKTR | NEKTAR THERAPEUTIC ... | CHESS ROBERT | Director | Option Exercise | A | 0.00 | 15,000 | 0 | 15,000 | |
| Sep 17 2015 | NKTR | NEKTAR THERAPEUTIC ... | CHESS ROBERT | Director | Option Exercise | A | 12.80 | 12,500 | 160,000 | 12,500 | |
| Sep 15 2015 | NKTR | NEKTAR THERAPEUTIC ... | WHITFIELD ROY A | Director | Option Exercise | M | 8.81 | 15,000 | 132,150 | 0 | |
| Sep 15 2015 | NKTR | NEKTAR THERAPEUTIC ... | WHITFIELD ROY A | Director | Buy | M | 8.81 | 15,000 | 132,150 | 15,000 | 0 to 15 K |
| Aug 17 2015 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP & General Couns ... | Option Exercise | M | 6.98 | 33,333 | 232,664 | 133,333 | |
| Aug 17 2015 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP & General Couns ... | Sell | S | 10.89 | 33,333 | 362,996 | 4,751 | 38.1 K to 4.8 K (-87.52 %) |
| Aug 17 2015 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP & General Couns ... | Buy | M | 6.98 | 33,333 | 232,664 | 38,084 | 4.8 K to 38.1 K (+701.60 %) |
| Aug 17 2015 | NKTR | NEKTAR THERAPEUTIC ... | ROBIN HOWARD W | President & CEO | Option Exercise | M | 6.98 | 58,333 | 407,164 | 583,333 | |
| Aug 17 2015 | NKTR | NEKTAR THERAPEUTIC ... | ROBIN HOWARD W | President & CEO | Sell | S | 10.89 | 58,333 | 635,246 | 10,000 | 68.3 K to 10 K (-85.37 %) |
| Aug 17 2015 | NKTR | NEKTAR THERAPEUTIC ... | ROBIN HOWARD W | President & CEO | Buy | M | 6.98 | 58,333 | 407,164 | 68,333 | 10 K to 68.3 K (+583.33 %) |
| Aug 13 2015 | NKTR | NEKTAR THERAPEUTIC ... | Nicholson John | SVP & Chief Financi ... | Option Exercise | M | 6.46 | 85,000 | 549,100 | 0 | |
| Aug 13 2015 | NKTR | NEKTAR THERAPEUTIC ... | Nicholson John | SVP & Chief Financi ... | Option Exercise | M | 6.98 | 5,000 | 34,900 | 0 | |
| Aug 13 2015 | NKTR | NEKTAR THERAPEUTIC ... | Nicholson John | SVP & Chief Financi ... | Option Exercise | M | 8.87 | 45,092 | 399,966 | 0 | |
| Aug 13 2015 | NKTR | NEKTAR THERAPEUTIC ... | Nicholson John | SVP & Chief Financi ... | Option Exercise | M | 6.98 | 95,000 | 663,100 | 5,000 | |
| Aug 13 2015 | NKTR | NEKTAR THERAPEUTIC ... | Nicholson John | SVP & Chief Financi ... | Option Exercise | M | 8.87 | 154,908 | 1,374,034 | 0 | |
| Aug 13 2015 | NKTR | NEKTAR THERAPEUTIC ... | Nicholson John | SVP & Chief Financi ... | Sell | S | 10.47 | 66,000 | 691,020 | 75,116 | 141.1 K to 75.1 K (-46.77 %) |
| Aug 13 2015 | NKTR | NEKTAR THERAPEUTIC ... | Nicholson John | SVP & Chief Financi ... | Buy | M | 6.46 | 85,000 | 549,100 | 141,116 | 56.1 K to 141.1 K (+151.47 %) |
| Aug 13 2015 | NKTR | NEKTAR THERAPEUTIC ... | Nicholson John | SVP & Chief Financi ... | Sell | S | 10.64 | 3,976 | 42,305 | 56,116 | 60.1 K to 56.1 K (-6.62 %) |
| Aug 13 2015 | NKTR | NEKTAR THERAPEUTIC ... | Nicholson John | SVP & Chief Financi ... | Buy | M | 6.98 | 5,000 | 34,900 | 60,092 | 55.1 K to 60.1 K (+9.08 %) |
| Aug 13 2015 | NKTR | NEKTAR THERAPEUTIC ... | Nicholson John | SVP & Chief Financi ... | Buy | M | 8.87 | 45,092 | 399,966 | 55,092 | 10 K to 55.1 K (+450.92 %) |
| Aug 13 2015 | NKTR | NEKTAR THERAPEUTIC ... | Nicholson John | SVP & Chief Financi ... | Sell | S | 10.67 | 95,000 | 1,013,650 | 10,000 | 105 K to 10 K (-90.48 %) |
| Aug 13 2015 | NKTR | NEKTAR THERAPEUTIC ... | Nicholson John | SVP & Chief Financi ... | Buy | M | 6.98 | 95,000 | 663,100 | 105,000 | 10 K to 105 K (+950.00 %) |
| Aug 13 2015 | NKTR | NEKTAR THERAPEUTIC ... | Nicholson John | SVP & Chief Financi ... | Sell | S | 10.99 | 154,908 | 1,702,439 | 10,000 | 164.9 K to 10 K (-93.94 %) |
| Aug 13 2015 | NKTR | NEKTAR THERAPEUTIC ... | Nicholson John | SVP & Chief Financi ... | Buy | M | 8.87 | 154,908 | 1,374,034 | 164,908 | 10 K to 164.9 K (+1,549.08 %) |
| Jul 28 2015 | NKTR | NEKTAR THERAPEUTIC ... | Krivulka Joseph J | Director | Option Exercise | M | 8.81 | 15,000 | 132,150 | 0 | |
| Jul 28 2015 | NKTR | NEKTAR THERAPEUTIC ... | Krivulka Joseph J | Director | Buy | M | 8.81 | 15,000 | 132,150 | 35,000 | 20 K to 35 K (+75.00 %) |
| Jul 16 2015 | NKTR | NEKTAR THERAPEUTIC ... | ROBIN HOWARD W | President & CEO | Option Exercise | M | 6.98 | 58,334 | 407,171 | 641,666 | |
| Jul 16 2015 | NKTR | NEKTAR THERAPEUTIC ... | ROBIN HOWARD W | President & CEO | Sell | S | 11.78 | 58,334 | 687,175 | 10,000 | 68.3 K to 10 K (-85.37 %) |
| Jul 16 2015 | NKTR | NEKTAR THERAPEUTIC ... | ROBIN HOWARD W | President & CEO | Buy | M | 6.98 | 58,334 | 407,171 | 68,334 | 10 K to 68.3 K (+583.34 %) |
| Jul 16 2015 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP & General Couns ... | Option Exercise | M | 6.98 | 33,334 | 232,671 | 166,666 | |
| Jul 16 2015 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP & General Couns ... | Sell | S | 11.78 | 33,334 | 392,675 | 4,251 | 37.6 K to 4.3 K (-88.69 %) |
| Jul 16 2015 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP & General Couns ... | Buy | M | 6.98 | 33,334 | 232,671 | 37,585 | 4.3 K to 37.6 K (+784.14 %) |
| Jul 01 2015 | NKTR | NEKTAR THERAPEUTIC ... | WANG SUSAN | Director | Option Exercise | M | 5.15 | 15,000 | 77,250 | 0 | |
| Jul 01 2015 | NKTR | NEKTAR THERAPEUTIC ... | WANG SUSAN | Director | Option Exercise | M | 8.81 | 15,000 | 132,150 | 0 | |
| Jul 01 2015 | NKTR | NEKTAR THERAPEUTIC ... | WANG SUSAN | Director | Sell | S | 12.70 | 15,000 | 190,500 | 20,000 | 35 K to 20 K (-42.86 %) |
| Jul 01 2015 | NKTR | NEKTAR THERAPEUTIC ... | WANG SUSAN | Director | Buy | M | 5.15 | 15,000 | 77,250 | 35,000 | 20 K to 35 K (+75.00 %) |
| Jul 01 2015 | NKTR | NEKTAR THERAPEUTIC ... | WANG SUSAN | Director | Sell | S | 12.70 | 15,000 | 190,500 | 20,000 | 35 K to 20 K (-42.86 %) |
| Jul 01 2015 | NKTR | NEKTAR THERAPEUTIC ... | WANG SUSAN | Director | Buy | M | 8.81 | 15,000 | 132,150 | 35,000 | 20 K to 35 K (+75.00 %) |
| Jun 23 2015 | NKTR | NEKTAR THERAPEUTIC ... | CHESS ROBERT | Director | Option Exercise | M | 8.81 | 15,000 | 132,150 | 0 | |
| Jun 23 2015 | NKTR | NEKTAR THERAPEUTIC ... | CHESS ROBERT | Director | Sell | S | 11.81 | 15,000 | 177,150 | 260,623 | 275.6 K to 260.6 K (-5.44 %) |
| Jun 23 2015 | NKTR | NEKTAR THERAPEUTIC ... | CHESS ROBERT | Director | Buy | M | 8.81 | 15,000 | 132,150 | 275,623 | 260.6 K to 275.6 K (+5.76 %) |
| Jun 17 2015 | NKTR | NEKTAR THERAPEUTIC ... | Lingnau Lutz | Director | Option Exercise | M | 6.65 | 25,000 | 166,250 | 12,500 | |
| Jun 17 2015 | NKTR | NEKTAR THERAPEUTIC ... | Lingnau Lutz | Director | Sell | S | 11.15 | 25,000 | 278,750 | 16,450 | 41.5 K to 16.5 K (-60.31 %) |
| Jun 17 2015 | NKTR | NEKTAR THERAPEUTIC ... | Lingnau Lutz | Director | Buy | M | 6.65 | 25,000 | 166,250 | 41,450 | 16.5 K to 41.5 K (+151.98 %) |
| Jan 15 2015 | NKTR | NEKTAR THERAPEUTIC ... | KUEBLER CHRISTOPHER A | Director | Option Exercise | M | 8.81 | 15,000 | 132,150 | 0 | |
| Jan 15 2015 | NKTR | NEKTAR THERAPEUTIC ... | KUEBLER CHRISTOPHER A | Director | Sell | S | 16.00 | 15,000 | 240,000 | 20,000 | 35 K to 20 K (-42.86 %) |
| Jan 15 2015 | NKTR | NEKTAR THERAPEUTIC ... | KUEBLER CHRISTOPHER A | Director | Buy | M | 8.81 | 15,000 | 132,150 | 35,000 | 20 K to 35 K (+75.00 %) |
| Dec 31 2014 | NKTR | NEKTAR THERAPEUTIC ... | CHESS ROBERT | Director | Option Exercise | M | 15.24 | 29,500 | 449,580 | 0 | |
| Dec 31 2014 | NKTR | NEKTAR THERAPEUTIC ... | CHESS ROBERT | Director | Sell | S | 15.34 | 29,500 | 452,530 | 260,623 | 290.1 K to 260.6 K (-10.17 %) |
| Dec 31 2014 | NKTR | NEKTAR THERAPEUTIC ... | CHESS ROBERT | Director | Buy | M | 15.24 | 29,500 | 449,580 | 290,123 | 260.6 K to 290.1 K (+11.32 %) |
| Dec 24 2014 | NKTR | NEKTAR THERAPEUTIC ... | Thomsen Jillian B. | SVP & Chief Account ... | Option Exercise | M | 11.38 | 5,000 | 56,900 | 0 | |
| Dec 24 2014 | NKTR | NEKTAR THERAPEUTIC ... | Thomsen Jillian B. | SVP & Chief Account ... | Sell | S | 15.56 | 5,000 | 77,800 | 2,999 | 8 K to 3 K (-62.51 %) |
| Dec 24 2014 | NKTR | NEKTAR THERAPEUTIC ... | Thomsen Jillian B. | SVP & Chief Account ... | Buy | M | 11.38 | 5,000 | 56,900 | 7,999 | 3 K to 8 K (+166.72 %) |
| Dec 11 2014 | NKTR | NEKTAR THERAPEUTIC ... | ROBIN HOWARD W | President & CEO | Option Exercise | A | 16.31 | 225,000 | 3,669,750 | 225,000 | |
| Dec 11 2014 | NKTR | NEKTAR THERAPEUTIC ... | ROBIN HOWARD W | President & CEO | Option Exercise | A | 16.31 | 225,000 | 3,669,750 | 225,000 | |
| Dec 11 2014 | NKTR | NEKTAR THERAPEUTIC ... | Nicholson John | SVP & Chief Financi ... | Option Exercise | A | 16.31 | 87,500 | 1,427,125 | 87,500 | |
| Dec 11 2014 | NKTR | NEKTAR THERAPEUTIC ... | Nicholson John | SVP & Chief Financi ... | Option Exercise | A | 16.31 | 87,500 | 1,427,125 | 87,500 | |
| Dec 11 2014 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP & General Couns ... | Option Exercise | A | 16.31 | 87,500 | 1,427,125 | 87,500 | |
| Dec 11 2014 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP & General Couns ... | Option Exercise | A | 16.31 | 87,500 | 1,427,125 | 87,500 | |
| Dec 11 2014 | NKTR | NEKTAR THERAPEUTIC ... | Hora Maninder | SVP Pharma Dev & Mf ... | Option Exercise | A | 16.31 | 50,000 | 815,500 | 50,000 | |
| Dec 11 2014 | NKTR | NEKTAR THERAPEUTIC ... | Hora Maninder | SVP Pharma Dev & Mf ... | Option Exercise | A | 16.31 | 50,000 | 815,500 | 50,000 | |
| Dec 11 2014 | NKTR | NEKTAR THERAPEUTIC ... | Gergel Ivan P. | SVP & Chief Medical ... | Option Exercise | A | 16.31 | 50,000 | 815,500 | 50,000 | |
| Dec 11 2014 | NKTR | NEKTAR THERAPEUTIC ... | Gergel Ivan P. | SVP & Chief Medical ... | Option Exercise | A | 16.31 | 50,000 | 815,500 | 50,000 | |
| Dec 11 2014 | NKTR | NEKTAR THERAPEUTIC ... | Doberstein Stephen K | SVP & Chief Scienti ... | Option Exercise | A | 16.31 | 50,000 | 815,500 | 50,000 | |
| Dec 11 2014 | NKTR | NEKTAR THERAPEUTIC ... | Doberstein Stephen K | SVP & Chief Scienti ... | Option Exercise | A | 16.31 | 50,000 | 815,500 | 50,000 | |
| Dec 11 2014 | NKTR | NEKTAR THERAPEUTIC ... | Thomsen Jillian B. | SVP & Chief Account ... | Option Exercise | A | 16.31 | 50,000 | 815,500 | 50,000 | |
| Dec 11 2014 | NKTR | NEKTAR THERAPEUTIC ... | Thomsen Jillian B. | SVP & Chief Account ... | Option Exercise | A | 16.31 | 50,000 | 815,500 | 50,000 | |
| Dec 02 2014 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP & General Couns ... | Option Exercise | M | 4.65 | 30,000 | 139,500 | 0 | |
| Dec 02 2014 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP & General Couns ... | Option Exercise | M | 4.65 | 90,000 | 418,500 | 30,000 | |
| Dec 02 2014 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP & General Couns ... | Sell | S | 17.00 | 30,000 | 510,000 | 4,251 | 34.3 K to 4.3 K (-87.59 %) |
| Dec 02 2014 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP & General Couns ... | Buy | M | 4.65 | 30,000 | 139,500 | 34,251 | 4.3 K to 34.3 K (+705.72 %) |
| Dec 02 2014 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP & General Couns ... | Sell | S | 17.02 | 90,000 | 1,531,800 | 4,251 | 94.3 K to 4.3 K (-95.49 %) |
| Dec 02 2014 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP & General Couns ... | Buy | M | 4.65 | 90,000 | 418,500 | 94,251 | 4.3 K to 94.3 K (+2,117.15 %) |
| Dec 02 2014 | NKTR | NEKTAR THERAPEUTIC ... | ROBIN HOWARD W | President & CEO | Option Exercise | M | 6.98 | 209,056 | 1,459,211 | 350,000 | |
| Dec 02 2014 | NKTR | NEKTAR THERAPEUTIC ... | ROBIN HOWARD W | President & CEO | Option Exercise | M | 6.98 | 140,944 | 983,789 | 559,056 | |
| Dec 02 2014 | NKTR | NEKTAR THERAPEUTIC ... | ROBIN HOWARD W | President & CEO | Sell | S | 17.00 | 209,056 | 3,553,952 | 10,000 | 219.1 K to 10 K (-95.43 %) |
| Dec 02 2014 | NKTR | NEKTAR THERAPEUTIC ... | ROBIN HOWARD W | President & CEO | Buy | M | 6.98 | 209,056 | 1,459,211 | 219,056 | 10 K to 219.1 K (+2,090.56 %) |
| Dec 02 2014 | NKTR | NEKTAR THERAPEUTIC ... | ROBIN HOWARD W | President & CEO | Sell | S | 17.02 | 140,944 | 2,398,867 | 10,000 | 150.9 K to 10 K (-93.38 %) |
| Dec 02 2014 | NKTR | NEKTAR THERAPEUTIC ... | ROBIN HOWARD W | President & CEO | Buy | M | 6.98 | 140,944 | 983,789 | 150,944 | 10 K to 150.9 K (+1,409.44 %) |
| Nov 26 2014 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP & General Couns ... | Option Exercise | M | 13.02 | 10,500 | 136,710 | 0 | |
| Nov 26 2014 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP & General Couns ... | Sell | S | 15.04 | 10,500 | 157,920 | 3,751 | 14.3 K to 3.8 K (-73.68 %) |
| Nov 26 2014 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP & General Couns ... | Buy | M | 13.02 | 10,500 | 136,710 | 14,251 | 3.8 K to 14.3 K (+279.93 %) |
| Nov 26 2014 | NKTR | NEKTAR THERAPEUTIC ... | ROBIN HOWARD W | President & CEO | Option Exercise | M | 14.52 | 467,200 | 6,783,744 | 0 |